首页 | 本学科首页   官方微博 | 高级检索  
     


Percutaneous radiofrequency ablation of hepatocellular carcinoma in the presence of portal vein thrombosis
Authors:Neeman Ziv  Libutti Steven K  Patti Jay W  Wood Bradford J
Affiliation:

a Imaging Sciences Program, Clinical Center, National Institutes of Health Building 10, Room 1C387, Bethesda, MD 20892, USA

b Surgery Branch, National Cancer Institute, National Institutes of Health, Building 10, Room 2B42, Bethesda, MD 20892, USA

c Georgetown University Medical Center, Washington, DC, USA

Abstract:Portal vein thrombosis (PVT) may not be an absolute contraindication for hepatic radiofrequency ablation (RFA). Although the data are sparse, PVT is commonly considered a contraindication to RFA. PVT has actually been described as a complication following RFA. RFA was used to treat a 3.9×2.9 cm primary hepatocellular carcinoma (HCC) in a patient with concomitant PVT without complication. RFA can be safely performed in this setting but further studies could clarify this issue.
Keywords:Hepatocellular carcinoma (HCC)   Portal vein thrombosis (PVT)   Radiofrequency ablation (RFA)
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号